SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-23-000048
Filing Date
2023-09-27
Accepted
2023-09-27 16:31:17
Documents
14
Period of Report
2023-09-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20230927x8k.htm   iXBRL 8-K 32764
2 EX-99.1 ibio-20230927xex99d1.htm EX-99.1 13715
  Complete submission text file 0001420720-23-000048.txt   173167

Data Files

Seq Description Document Type Size
3 EX-101.SCH ibio-20230927.xsd EX-101.SCH 4159
4 EX-101.DEF ibio-20230927_def.xml EX-101.DEF 3258
5 EX-101.LAB ibio-20230927_lab.xml EX-101.LAB 13975
6 EX-101.PRE ibio-20230927_pre.xml EX-101.PRE 10318
8 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20230927x8k_htm.xml XML 4615
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231285102
SIC: 2834 Pharmaceutical Preparations